ArticleInternational journal of health policy and management2016
Looking Beyond FDA Warning Letters to Explore Unforeseen Trouble Spots in eDTCA: A Response to Recent Commentaries.
Hyosun KimPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.